ArticleJournal of psoriasis and psoriatic arthritisPublished
Icotrokinra, a Targeted Oral Peptide, in Participants With Moderate-to-Severe Plaque Psoriasis and Self-Reported Psoriatic Arthritis: Results From a Pooled Analysis of the Phase 3 ICONIC-LEAD, ICONIC-ADVANCE 1, and ICONIC-ADVANCE 2 Trials
Regional connection
Verified Author affiliations on the Europe PMC record name Drexel University College of Medicine, Johnson & Johnson, with Drexel University linked by the institution reference. Affiliation source
- Counties
- Montgomery County, Philadelphia County
Publication record
- Type
- Article
- Venue
- Journal of psoriasis and psoriatic arthritis
- Published
- Topic
- Clinical care
- Subject terms
- Psoriatic Arthritis; Plaque Psoriasis; Patient-reported Outcomes; Interleukin-23 Receptor; Oral Peptide; Interleukin-23 Inhibition; Icotrokinra
- PubMed ID
- 42898453
- PubMed Central ID
- PMC13677984
- Open access
- Yes, open
- Added to directory
- Source checked